Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Burcon NutraScience Corp files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
Revenue
0.03
0.26
0.17
Research and development
0.72
0.41
1.85
Operating income
-3.72
-4.6
-7.4
Interest income
0.25
0.45
0.43
Income tax
0
0
0
Net income
-4.63
-0.62
-10.3
EPS, basic
-0.06
-0.01
EPS, diluted
-0.06
-0.01
-0.09
Balance sheet
FY2021
FY2021
FY2022
Cash and equivalents
15
14
7
Receivables
0.33
0.34
0.2
Inventory
0.13
0.13
0
Total current assets
15.8
14.6
7.62
Property, plant and equipment
0.47
1.01
0.86
Goodwill
1.25
1.25
1.25
Total assets
31.3
37.7
29.3
Accounts payable
1.07
1.42
0.91
Total current liabilities
1.59
1.45
1.04
Lease liabilities
0
0.01
0.06
Total liabilities
8.32
1.45
1.1
Retained earnings
-98.4
-99
-109
Total equity
22.9
36.3
28.2
Total liabilities and equity
31.3
37.7
29.3
Cash flow statement
FY2021
FY2021
FY2022
Net income
-4.63
-0.62
-10.3
Cash from operations
-3.37
-3.03
-5.91
Capital expenditures
-0.1
-0.89
-0.05
Cash from investing
-14.5
-2.72
-1.23
Stock issued
25.8
5.03
0.27
Cash from financing
32.4
4.7
0.17
Exchange rate effect
0
-0
-0
Net change in cash
14.5
-1.06
-6.97
Free cash flow
-3.47
-3.93
-5.97
Interest paid
0.67
0.57
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2022. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Operating margin
-4,314.0%
Operating income / revenue.
Net margin
-5,983.0%
Net income / revenue.
FCF margin
-3,479.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-3,449.0%
Cash from operations / revenue.
Return on assets (ROA)
-30.6%
Net income / average total assets.
R&D / revenue
1,076.0%
Research and development expense / revenue.
Capex / revenue
30.0%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-33.7%
Revenue vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-22.2%
Total assets vs the same period a year earlier. Only from a positive base.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
7.30x
Current assets / current liabilities.
Quick ratio
6.90x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
6.71x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
3.8%
Total liabilities / total assets.
Working capital
CA$6.6M
Current assets - current liabilities.
Goodwill and intangibles / assets
4.3%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.01x
Revenue / average total assets.
Fixed asset turnover
0.18x
Revenue / average property, plant and equipment.
Receivables turnover
0.64x
Revenue / average receivables.
Days sales outstanding
574 days
365 x average receivables / revenue.
Per share
Metric
Value
How it is calculated
EPS, diluted
-CA$0.09
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
What was Burcon NutraScience Corp's revenue in fiscal 2022?
Burcon NutraScience Corp reported revenue of CA$171.5K for fiscal 2022, 33.7% lower than the year before.
Was Burcon NutraScience Corp profitable in fiscal 2022?
No. It reported a net loss of CA$10.3M.
How much free cash flow did Burcon NutraScience Corp generate in fiscal 2022?
Cash from operations of CA$5.9M minus capital expenditures of CA$51.5K left free cash flow of -CA$6.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.